other material
confidence high
sentiment negative
materiality 0.60
BioXcel Therapeutics shareholders approve reverse stock split range of 1:5 to 1:30
BioXcel Therapeutics, Inc.
- Proposal 1 passed with ~90.8% of votes cast in favor (27.6M for, 2.5M against, 0.3M abstain).
- Proposal 2 (adjournment) also approved with ~91.5% of votes cast in favor (27.7M for).
- Board retains discretion to select exact split ratio between 1:5 and 1:30 at a later date.
- Approximately 61.2% of outstanding common stock (30.4M shares) was represented at the special meeting.